Abbott Laboratories buy Freedom Capital
Start price
31.01.26
/
50%
€92.30
Target price
31.01.27
-
Performance (%)
2.52%
Price
13.03.26
€94.63
Summary
This prediction is currently active. With a performance of 2.52%, the BUY prediction by Freedom_Capital for Abbott Laboratories is trending in the right direction. This prediction currently runs until 31.01.27. The prediction end date can be changed by Freedom_Capital at any time. Freedom_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 0.767% | 0.767% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by Freedom_Capital for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
Ratings data for ABT provided by MarketBeat